共 37 条
[1]
Grever M.R., Leiby J., Kraut E., Metz E., Neidhart J., Balcerzak S., Malspeis L., A comprehensive phase I and II clinical investigations of fludarabine phosphate, Semin. Oncol., 17, Suppl 8, pp. 39-48, (1990)
[2]
Von Hoff D.D., Phase I clinical trials with fludarabine phosphate, Semin. Oncol., 17, pp. 33-38, (1990)
[3]
Grever M.R., Coltman C.A., Files J.C., Fludarabine monophosphate in chronic lymphocytic leukemia, Blood, 68, (1986)
[4]
Keating M.J., Kantarjian H., O'Brien S., Fludarabine: A new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia, J. Clin. Oncol, 9, pp. 44-49, (1991)
[5]
Keating M.J., Kantarjian H., Talpaz M., Fludarabine: A new agent with major activity against chronic lymphocytic leukemia, Blood, 74, pp. 19-25, (1989)
[6]
Redman J.R., Cabanillas F., Velasquez W.S., Phase II trial of fludarabine phosphate in lymphoma: An effective new agent in low-grade lymphoma, J. Clin. Oncol, 10, pp. 790-794, (1992)
[7]
Hochster H.S., Kim K., Green M.D., Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: Results of an Eastern Cooperative Oncology Group study, J. Clin. Oncol, 10, pp. 28-32, (1992)
[8]
Plunkett W., Huang P., Gandhi V., Metabolism and action of fludarabine phosphate, Semin. Oncol, 17, pp. 3-17, (1990)
[9]
Grever M.R., Kopecky K.J., Coltman C.A., Files J.C., Greenberg B.R., Fludarabine monophosphate: A potentially useful agent in chronic lymphocytic leukemia, Nouvell Revue Francaise d'Hematologic, 30, pp. 457-459, (1988)
[10]
Cheson B.D., Bennett J.M., Rai K.R., Grever M.R., Kay N.E., Schiffer C.A., Oken M.M., Keating M.J., Boldt D.H., Kempin S.J., Foon K.A., Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the National Cancer Institute Sponsored Working Group, Am. J. Hematol., 29, pp. 152-163, (1988)